Nephrology & Urology Devices Market Size Worth $31.3 Billion by 2024: Grand View Research, Inc.
SAN FRANCISCO, June 19, 2018 /PRNewswire/ --
The global nephrology and urology devices market size is expected to reach USD 31.3 billion by 2024, according to a new report by Grand View Research, Inc., exhibiting a 7.1% CAGR during the forecast period. Increasing prevalence of chronic kidney diseases is expected to fuel market growth.
This high prevalence of diseases can be attributed to unhealthy lifestyle habits of people around the world. Moreover, growing geriatric population, who are more prone to hypertension, obesity, diabetes, urinary disorders, and other kidney chronic conditions, is expected to fuel demand for nephrology and urology devices.
Advancements in device technology, such as inclusion of prosthetics in urology, percutaneous methods for stone disintegration and extraction, and extracorporeal shockwave lithotripsy, are anticipated to boost the market over the forecast period. Furthermore, presence of highly advanced pipeline products such as bioartificial kidney is presumed to present the market with lucrative growth opportunities in future.
Increase in demand for minimally invasive techniques is also likely to propel the market in the coming years. Nephrology and urology devices facilitate early diagnosis and shorter treatment duration in most surgical procedures. Minimal pain, heightened cost efficiency, safety, efficacy, rapid recovery, and reduced hospital stay are other benefits offered by these devices. This is expected to boost adoption over the forecast period.
Browse full research report with TOC on "Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024" at:https://www.grandviewresearch.com/industry-analysis/nephrology-urology-devices-market
Further Key Findings From the Report Suggest:
The global urology segment is anticipated to reach USD 21.4 billion by 2024, at a CAGR of 6.9% from 2016 to 2024
By type, the benign prostatic hyperplasia segment is anticipated to witness lucrative growth over the forecast period
Europe held the dominant revenue share as of 2015 owing to a large target population. Growth across this region is primarily driven by presence of prominent market players implementing extensive expansion strategies such as product development and mergers and acquisitions
Asia Pacific, especially countries such as India and China, is expected to observe remarkable growth in the coming years
The global industry is dominated by few players and is marked by extensive new product development and high-end investments in R&D. Level of competition is expected to remain high over the forecast period
Some of the key players in the market are Baxter International, Inc.; Fresenius Medical Care AG & Co. KGaA; Boston Scientific; and C.R. Bard Inc.
Medical Electronics Market - The global medical electronics market was estimated to be around USD 94 billion in 2015 and is projected to grow at a CAGR of 7.9% over the next nine years.
Obesity Treatment Market - The global obesity treatment market was valued at USD 3.9 billion in 2015.
Grand View Research has segmented the global nephrology and urology devices market on the basis of type and region:
Nephrology and Urology Devices Type Outlook (Revenue, USD Billion, 2013 - 2024)
Dialysis
Urinary Stone
Ureteral stents
Lithotripters
Urinary Incontinence & Pelvic Organ Prolapsed
Sacral neuromodulation
Vaginal meshes & slings
Ureteral inserts & pessaries
Benign Prostatic Hyperplasia
Catheter ablation
Prostatic stents
Endoscopy
Others
Nephrology and Urology Devices Regional Outlook (Revenue, USD Billion, 2013 - 2024)
North America
U.S.
Canada
Europe
U.K.
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Explore the BI enabled intuitive market research database,The Grand Library, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Revvity's EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits...
Fx Chocolate®, a Designs for Health brand that provides functional amounts of high-quality supplements in handcrafted chocolate, today announced the launch of its Yes Whey!!!tm chocolate supplement bar. Yes Whey!!!tm harnesses 15 grams of...
Varian, a Siemens Healthineers Company, announces its collaboration with BaraSeen Medical Company to introduce the first Halcyon system in Saudi Arabia - with its hallmark sustainability features - at BaraSeen's initial specialized standalone Batik-X...
From the childhood dream of becoming a veterinarian and saving the lives of pets, to today's realities of practicing veterinary medicine, the deep commitment veterinarians feel for their calling remains unchanged. However, certain factors make that...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical...
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....